Replies to post #1178 on Israel-Medical-Healthcare

[genisi]

You can compare the language used by the FDA:

Brainsway's device is approved for the treatment of Major Depressive Disorder in patients who have failed to respond to antidepressant medications in their current episode of depression.

Neuronetics' device is approved for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.

Antidepressants are 1st line and a patient can try one of the TMS treatments before ECT.